LA Jolla Pharmaceuticals Co (LJPC) Covered Calls

LA Jolla Pharmaceuticals Co covered calls La Jolla Pharmaceutical Co. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutics for chronic organ failure and cancer.

You can sell covered calls on LA Jolla Pharmaceuticals Co to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for LJPC (prices last updated Tue 10:50 AM ET):

LA Jolla Pharmaceuticals Co (LJPC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
13.71 -0.10 13.67 13.71 56K - 0.0B
Covered Calls For LA Jolla Pharmaceuticals Co (LJPC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 14 0.00 13.71 0.0% 0.0%
Jan 18 14 0.20 13.51 1.5% 14.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

La Jolla Pharmaceutical Co. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics intended to significantly improve outcomes in patients with life-threatening diseases. It focuses on three product candidates: GCS-100, LJPC-501 and LJPC-401. The GCS-100 targets the protein galectin-3, which, when overproduced by the human body, has been associated with chronic organ failure and cancer. The LJPC-501 is a peptide agonist of the renin-angiotensin system, which is designed to help restore kidney function in patients with hepatorenal syndrome. The LJPC-401 product will be evaluated for the treatment of iron disorders. The company also plan to continue to evaluate other opportunities for potential product candidates for the treatment of unmet medical needs. La Jolla Pharmaceutical was founded in 1989 and is headquartered in San Diego, CA.